Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effects
Author:
Publisher
Georg Thieme Verlag KG
Subject
Hematology
Link
http://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH15-04-0324.pdf
Reference15 articles.
1. Benefit–risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism
2. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
3. New oral anticoagulant agents – general features and outcomes in subsets of patients
4. The perioperative management of new direct oral anticoagulants: a question without answers
5. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Repeated Administration of Idarucizumab to a Patient with Dabigatran Overdose;Hämostaseologie;2018-02
2. Dabigatran in nonvalvular atrial fibrillation;Journal of Cardiovascular Medicine;2017-07
3. Editors’ Choice 2016 papers in Thrombosis and Haemostasis;Thrombosis and Haemostasis;2017
4. Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention;F1000Research;2016-12-20
5. Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents;Current Drug Therapy;2016-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3